The factors affecting the survivability of malignant cancer patients with deep vein thrombosis among subjects with gynecologic and non-gynecologic cancer: An ambispective cohort study

  • 0Division of Hematology and Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Central Jakarta, Jakarta, 10430, Indonesia.

|

|

Summary

This summary is machine-generated.

Cancer patients with deep vein thrombosis (DVT) face high short-term mortality. Immobilization, infection, and advanced cancer stages significantly reduce survival, underscoring the need for preventative measures.

Area Of Science

  • Oncology
  • Hematology
  • Public Health

Background

  • Gynecologic cancers are a major global health issue, with a notable incidence among women.
  • Deep vein thrombosis (DVT) presents a significant challenge in cancer care, leading to poorer patient outcomes.
  • This study addresses the critical need to understand factors influencing survival in cancer patients with DVT.

Purpose Of The Study

  • To analyze factors impacting the survivability of cancer patients diagnosed with deep vein thrombosis (DVT).
  • To specifically compare survival outcomes between gynecologic and non-gynecologic cancer patients with DVT.

Main Methods

  • An ambispective cohort study involving 223 cancer patients with DVT.
  • Data collected from January 2011 to August 2013, with a three-month observation period.
  • Kaplan-Meier survival analysis and log-rank/Mantel-Cox tests were employed to determine statistical significance.

Main Results

  • Overall, 61.4% of cancer patients with DVT experienced short-term mortality.
  • Immobilization, advanced cancer stage, and infection were significant predictors of reduced survival in the overall cohort.
  • Specific risk factors varied between gynecologic and non-gynecologic cancers, with pneumonia being the most common infection.

Conclusions

  • Cancer patients with DVT, both gynecologic and non-gynecologic, exhibit high short-term mortality rates.
  • Immobility, infection, advanced cancer stage, systemic therapy, and cancer surgery are critical risk factors affecting survival.
  • Implementing secondary prophylaxis is essential for improving outcomes in this patient population.

Related Concept Videos

Disorders of Hemostasis 01:24

716

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

The first is the irregular texture of blood vessels, which can...

Cancer Survival Analysis 01:21

328

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Disorders of the Female Reproductive System 01:24

329

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Venous Return 01:04

3.1K

The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Anticoagulant Drugs: Low-Molecular-Weight Heparins 01:30

624

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...